Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001610717-25-000380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-11-14 | 2025-11-12 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $65.07 | -20.0K | 247.9K | -7% | -$1.30M |
| DT | 2025-11-14 | 2025-11-12 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +20.0K | 267.9K | +8% | +$81.8K |
| DT | 2025-11-14 | 2025-11-12 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -20.0K | 157.7K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | S | D | 20,000 | $65.07 | 247,863 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $65.00 to $65.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 193,475 restricted stock units. |
| 2 | Common | Common Stock | 2025-11-12 | M | A | 20,000 | $4.09 | 267,863 | D | — | — | (F2) Includes 193,475 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-12 | M | D | 20,000 | $0.00 | 157,708 | D | $4.09 · 2023-03-13 to 2029-03-12 | 20,000 Common Stock |